{"id":"W4310117789","doi":"10.1007/s00277-022-05060-x","title":"EBV-positive diffuse large B-cell lymphoma following alemtuzumab therapy for T-cell prolymphocytic leukemia","year":2022,"lang":"en","type":"letter","venue":"Annals of Hematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Alemtuzumab; Prolymphocytic leukemia; Hematology; Medicine; Lymphoma; Internal medicine; Leukemia; Oncology; Cancer research; Pathology; Immunology; Chronic lymphocytic leukemia; Transplantation","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0007851772,0.0009914646,0.002926881,0.0007964532,0.0003242025,0.00003999133,0.001031223,0.001715185,0.0004247766],"category_scores_gemma":[0.0002971146,0.0009216044,0.001790305,0.0004995454,0.0003109557,0.0001206122,0.0005065943,0.001338044,0.00008480824],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.007772031,"about_ca_system_score_gemma":0.02511386,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004488027,"about_ca_topic_score_gemma":0.000007384436,"domain_scores_codex":[0.9928397,0.0004583441,0.001430222,0.00151172,0.001432666,0.002327383],"domain_scores_gemma":[0.9945999,0.00214047,0.0008403726,0.001756332,0.0003832915,0.0002795883],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.003393265,0.002869968,0.00004405578,0.004176909,0.001304718,0.009198869,0.0006790868,0.000002079734,0.0008160388,0.0002206182,0.9765199,0.0007744919],"study_design_scores_gemma":[0.1725584,0.004515774,0.000009176163,0.0005059206,0.0005095568,0.002559446,0.0002496493,0.001488334,0.1132276,0.0005810971,0.7026842,0.001110922],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"commentary","genre_scores_codex":[0.6215331,0.04995803,0.0005285019,0.2894381,0.002692573,0.01533249,0.001928074,0.0005583592,0.01803082],"genre_scores_gemma":[0.4389295,0.002221713,0.0004951176,0.5370988,0.001624564,0.002450148,0.004053514,0.000685344,0.01244134],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.2738357,"threshold_uncertainty_score":0.9995808,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04180540435871588,"score_gpt":0.3331331674825112,"score_spread":0.2913277631237953,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}